2-58146317-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006296.7(VRK2):āc.1025T>Cā(p.Val342Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000079 in 1,607,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006296.7 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VRK2 | NM_006296.7 | c.1025T>C | p.Val342Ala | missense_variant, splice_region_variant | 12/13 | ENST00000340157.9 | NP_006287.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VRK2 | ENST00000340157.9 | c.1025T>C | p.Val342Ala | missense_variant, splice_region_variant | 12/13 | 1 | NM_006296.7 | ENSP00000342381 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151930Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248302Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134222
GnomAD4 exome AF: 0.0000825 AC: 120AN: 1455396Hom.: 0 Cov.: 30 AF XY: 0.0000815 AC XY: 59AN XY: 723996
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.1025T>C (p.V342A) alteration is located in exon 12 (coding exon 11) of the VRK2 gene. This alteration results from a T to C substitution at nucleotide position 1025, causing the valine (V) at amino acid position 342 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at